Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- Low-dose anticoagulation shows promise beyond stroke, VTE prevention
-
- New iteration of EES receives FDA approval
- Adding vasopressin to catecholamines may lower AF risk in distributive shock
- Genetic predisposition to CHD alters risk associated with smoking
- PCI public reporting programs may confer interventionalist risk aversion
- Preoperative walk distance predicts cognitive dysfunction after cardiac surgery
- Protein intake may increase HF risk in men
- Social isolation increases risk for death in HF
- Statewide STEMI destination policies confer faster treatment times
-
- USPSTF: ECG insufficient to screen for CVD in asymptomatic patients
- Manufacturer, pharmacy provider agree to alirocumab price drop, simplified access
- Insufficient sleep affects BP control in cardiometabolic syndrome
- Cardiac contractility modulation improves HFrEF outcomes
- Continuous care with nutritional ketosis improves CVD risk
- FAME 2: FFR-guided PCI leads to better outcomes than medical therapy in stable CAD
- Hope for renal denervation revived with new sham-controlled trials
- Inclisiran reduces LDL in variety of populations
-
- Menopause may play role in CVD risk in older women
- Novel method enhances accuracy of LDL estimates
- ORBITA analysis: FFR, iFR may predict PCI effect on stress echo ischemia
- Pacemaker best option for older patients with syncope, bifascicular block
- Sacubitril/valsartan improves health status in real-world HFrEF cohort
- Study calls attention to thrombosis following LAA occlusion
- Thromboembolic risk greater with direct oral anticoagulants vs. warfarin when adherence low
- Volanesorsen reduces pancreatitis, triglycerides in familial chylomicronemia
-
- Trial Scorecard: ACTIVE REWARD
- Trial Scorecard: BIO-RESORT
- Trial Scorecard: CARPREG II
- Trial Scorecard: ENHANCE CRT
- Trial Scorecard: FAME 2
- Trial Scorecard: SPRITELY (POST 3)
- Trial Scorecard: SWAP-4
- Trial Scorecard: WAKE-UP
-